{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:21:52Z","timestamp":1793467312484,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T00:00:00Z","timestamp":1393891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00277-014-2031-2","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T17:52:33Z","timestamp":1393869153000},"page":"1305-1312","source":"Crossref","is-referenced-by-count":64,"title":["Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era"],"prefix":"10.1007","volume":"93","author":[{"given":"Samir","family":"Dalia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Chervenick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubomir","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Sotomayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,4]]},"reference":[{"issue":"3","key":"2031_CR1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/107327481201900305","volume":"19","author":"JL Cultrera","year":"2012","unstructured":"Cultrera JL, Dalia SM (2012) Diffuse large B-cell lymphoma: current strategies and future directions. Cancer Control 19(3):204\u2013213","journal-title":"Cancer Control"},{"key":"2031_CR2","doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) N Engl J Med 329(14):987-994. doi: 10.1056\/nejm199309303291402","DOI":"10.1056\/NEJM199309303291402"},{"issue":"4","key":"2031_CR3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346(4):235\u2013242. doi: 10.1056\/NEJMoa011795","journal-title":"N Engl J Med"},{"issue":"12","key":"2031_CR4","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","volume":"116","author":"B Coiffier","year":"2010","unstructured":"Coiffier B, Thieblemont C, Van Den Neste E, Lepeu G, Plantier I, Castaigne S, Lefort S, Marit G, Macro M, Sebban C, Belhadj K, Bordessoule D, Ferme C, Tilly H (2010) Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte. Blood 116(12):2040\u20132045. doi: 10.1182\/blood-2010-03-276246","journal-title":"Blood"},{"issue":"5","key":"2031_CR5","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","volume":"109","author":"LH Sehn","year":"2007","unstructured":"Sehn LH, Berry B, Chhanabhai M, Fitzgerald C, Gill K, Hoskins P, Klasa R, Savage KJ, Shenkier T, Sutherland J, Gascoyne RD, Connors JM (2007) The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 109(5):1857\u20131861. doi: 10.1182\/blood-2006-08-038257","journal-title":"Blood"},{"issue":"5","key":"2031_CR6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1470-2045(11)70069-9","volume":"12","author":"F Peyrade","year":"2011","unstructured":"Peyrade F, Jardin F, Thieblemont C, Thyss A, Emile JF, Castaigne S, Coiffier B, Haioun C, Bologna S, Fitoussi O, Lepeu G, Fruchart C, Bordessoule D, Blanc M, Delarue R, Janvier M, Salles B, Andre M, Fournier M, Gaulard P, Tilly H (2011) Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80\u00a0years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. Lancet Oncol 12(5):460\u2013468. doi: 10.1016\/s1470-2045(11)70069-9","journal-title":"Lancet Oncol"},{"issue":"1","key":"2031_CR7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/172460089300800103","volume":"8","author":"AN Pavlidis","year":"1993","unstructured":"Pavlidis AN, Kalef-Ezra J, Bourantas LC, Lambrou A, Mavridis A (1993) Serum tumor markers in non-Hodgkin\u2019s lymphomas and chronic lymphocytic leukemia. Int J Biol Markers 8(1):14\u201320","journal-title":"Int J Biol Markers"},{"issue":"1\u20132","key":"2031_CR8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/10428199809059259","volume":"32","author":"J Suzumiya","year":"1998","unstructured":"Suzumiya J, Ohshima K, Kanda M, Kato A, Shuuda K, Kimura N, Tamura K, Kikuchi M (1998) Intravascular large cell lymphoma associated with hypoalbuminemia. Leuk Lymphoma 32(1\u20132):179\u2013182. doi: 10.3109\/10428199809059259","journal-title":"Leuk Lymphoma"},{"issue":"Suppl","key":"2031_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10428199309149113","volume":"10","author":"B Coiffier","year":"1993","unstructured":"Coiffier B, Lepage E (1993) Prognostic factors in large-cell lymphomas. Leuk Lymphoma 10(Suppl):57\u201360. doi: 10.3109\/10428199309149113","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"2031_CR10","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","volume":"121","author":"H Horn","year":"2013","unstructured":"Horn H, Ziepert M, Becher C, Barth TF, Bernd HW, Feller AC, Klapper W, Hummel M, Stein H, Hansmann ML, Schmelter C, Moller P, Cogliatti S, Pfreundschuh M, Schmitz N, Trumper L, Siebert R, Loeffler M, Rosenwald A, Ott G (2013) MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood 121(12):2253\u20132263. doi: 10.1182\/blood-2012-06-435842","journal-title":"Blood"},{"issue":"9","key":"2031_CR11","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/leu.2012.83","volume":"26","author":"C Visco","year":"2012","unstructured":"Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Tzankov A, Wen W, Liu WM, Kahl BS, d\u2019Amore ES, Montes-Moreno S, Dybkaer K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Winter JN, Wang HY, O\u2019Neill S, Dunphy CH, Hsi ED, Zhao XF, Go RS, Choi WW, Zhou F, Czader M, Tong J, Zhao X, van Krieken JH, Huang Q, Ai W, Etzell J, Ponzoni M, Ferreri AJ, Piris MA, Moller MB, Bueso-Ramos CE, Medeiros LJ, Wu L, Young KH (2012) Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia 26(9):2103\u20132113. doi: 10.1038\/leu.2012.83","journal-title":"Leukemia"},{"key":"2031_CR12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1182\/asheducation.V2012.1.402.3798516","volume":"2012","author":"LH Sehn","year":"2012","unstructured":"Sehn LH (2012) Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma. Hematol Am Soc Hematol Educ Prog 2012:402\u2013409. doi: 10.1182\/asheducation-2012.1.402","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"issue":"3","key":"2031_CR13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/107327481201900306","volume":"19","author":"AM Perry","year":"2012","unstructured":"Perry AM, Mitrovic Z, Chan WC (2012) Biological prognostic markers in diffuse large B-cell lymphoma. Cancer Control 19(3):214\u2013226","journal-title":"Cancer Control"},{"issue":"3","key":"2031_CR14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/10428190701809156","volume":"49","author":"L Ngo","year":"2008","unstructured":"Ngo L, Hee SW, Lim LC, Tao M, Quek R, Yap SP, Loong EL, Sng I, Hwan-Cheong TL, Ang MK, Ngeow J, Tham CK, Tan MH, Lim ST (2008) Prognostic factors in patients with diffuse large B cell lymphoma: before and after the introduction of rituximab. Leuk Lymphoma 49(3):462\u2013469. doi: 10.1080\/10428190701809156","journal-title":"Leuk Lymphoma"},{"key":"2031_CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2891-9-69","volume":"9","author":"D Gupta","year":"2010","unstructured":"Gupta D, Lis CG (2010) Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 9:69. doi: 10.1186\/1475-2891-9-69","journal-title":"Nutr J"},{"issue":"6","key":"2031_CR16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0895-4356(97)00015-2","volume":"50","author":"P Goldwasser","year":"1997","unstructured":"Goldwasser P, Feldman J (1997) Association of serum albumin and mortality risk. J Clin Epidemiol 50(6):693\u2013703","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"2031_CR17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0003-9993(96)90081-7","volume":"77","author":"HM Finestone","year":"1996","unstructured":"Finestone HM, Greene-Finestone LS, Wilson ES, Teasell RW (1996) Prolonged length of stay and reduced functional improvement rate in malnourished stroke rehabilitation patients. Arch Phys Med Rehabil 77(4):340\u2013345","journal-title":"Arch Phys Med Rehabil"},{"issue":"11","key":"2031_CR18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0025-6196(12)65505-0","volume":"63","author":"MJ Murray","year":"1988","unstructured":"Murray MJ, Marsh HM, Wochos DN, Moxness KE, Offord KP, Callaway CW (1988) Nutritional assessment of intensive-care unit patients. Mayo Clin Proc 63(11):1106\u20131115","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"2031_CR19","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3109\/10428190903318311","volume":"50","author":"D Chihara","year":"2009","unstructured":"Chihara D, Oki Y, Ine S, Yamamoto K, Kato H, Taji H, Kagami Y, Yatabe Y, Nakamura S, Morishima Y (2009) Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy. Leuk Lymphoma 50(12):1999\u20132004. doi: 10.3109\/10428190903318311","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"2031_CR20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3109\/10428191003721359","volume":"51","author":"T Watanabe","year":"2010","unstructured":"Watanabe T, Kinoshita T, Itoh K, Yoshimura K, Ogura M, Kagami Y, Yamaguchi M, Kurosawa M, Tsukasaki K, Kasai M, Tobinai K, Kaba H, Mukai K, Nakamura S, Ohshima K, Hotta T, Shimoyama M (2010) Pretreatment total serum protein is a significant prognostic factor for the outcome of patients with peripheral T\/natural killer-cell lymphomas. Leuk Lymphoma 51(5):813\u2013821. doi: 10.3109\/10428191003721359","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2031_CR21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12185-011-0898-4","volume":"94","author":"YJ Zhu","year":"2011","unstructured":"Zhu YJ, Huang JJ, Xia Y, Zhao W, Jiang WQ, Lin TY, Huang HQ, Li ZM (2011) Primary mediastinal large B-cell lymphoma (PMLBCL) in Chinese patients: clinical characteristics and prognostic factors. Int J Hematol 94(2):178\u2013184. doi: 10.1007\/s12185-011-0898-4","journal-title":"Int J Hematol"},{"issue":"21","key":"2031_CR22","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","volume":"339","author":"D Hasenclever","year":"1998","unstructured":"Hasenclever D, Diehl V (1998) A prognostic score for advanced Hodgkin\u2019s disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 339(21):1506\u20131514. doi: 10.1056\/nejm199811193392104","journal-title":"N Engl J Med"},{"issue":"12","key":"2031_CR23","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","volume":"107","author":"L Arcaini","year":"2006","unstructured":"Arcaini L, Lazzarino M, Colombo N, Burcheri S, Boveri E, Paulli M, Morra E, Gambacorta M, Cortelazzo S, Tucci A, Ungari M, Ambrosetti A, Menestrina F, Orsucci L, Novero D, Pulsoni A, Frezzato M, Gaidano G, Vallisa D, Minardi V, Tripodo C, Callea V, Baldini L, Merli F, Federico M, Franco V, Iannitto E, Integruppo Italiano L (2006) Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 107(12):4643\u20134649. doi: 10.1182\/blood-2005-11-4659","journal-title":"Blood"},{"issue":"3","key":"2031_CR24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbmt.2010.07.011","volume":"17","author":"MA Kharfan-Dabaja","year":"2011","unstructured":"Kharfan-Dabaja MA, Chavez JC, Yu D, Zhu W, Fernandez-Vertiz EI, Perkins J, Shapiro J, Bookout R, Perez L, Fernandez HF, Komrokji RS, Lancet J, Brand L, Field T, Ayala E, Janssen W, List AF, Anasetti C (2011) Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant 17(3):384\u2013393. doi: 10.1016\/j.bbmt.2010.07.011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2031_CR25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/ajh.23303","volume":"87","author":"RS Komrokji","year":"2012","unstructured":"Komrokji RS, Corrales-Yepez M, Kharfan-Dabaja MA, Al Ali NH, Padron E, Rollison DE, Pinilla-Ibarz J, Zhang L, Epling-Burnette PK, Lancet JE, List AF (2012) Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes. Am J Hematol 87(11):1006\u20131009. doi: 10.1002\/ajh.23303","journal-title":"Am J Hematol"},{"issue":"5","key":"2031_CR26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25(5):579\u2013586. doi: 10.1200\/jco.2006.09.2403","journal-title":"J Clin Oncol"},{"key":"2031_CR27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","volume":"69","author":"D Schoenfeld","year":"1982","unstructured":"Schoenfeld D (1982) Partial residuals for the proportional hazards regression model. Biometrika 69:239\u2013241","journal-title":"Biometrika"},{"issue":"11","key":"2031_CR28","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1182\/blood-2012-05-430389","volume":"120","author":"AM Perry","year":"2012","unstructured":"Perry AM, Cardesa-Salzmann TM, Meyer PN, Colomo L, Smith LM, Fu K, Greiner TC, Delabie J, Gascoyne RD, Rimsza L, Jaffe ES, Ott G, Rosenwald A, Braziel RM, Tubbs R, Cook JR, Staudt LM, Connors JM, Sehn LH, Vose JM, Lopez-Guillermo A, Campo E, Chan WC, Weisenburger DD (2012) A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma. Blood 120(11):2290\u20132296. doi: 10.1182\/blood-2012-05-430389","journal-title":"Blood"},{"issue":"26","key":"2031_CR29","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1182\/blood-2011-04-345256","volume":"117","author":"G Salles","year":"2011","unstructured":"Salles G, de Jong D, Xie W, Rosenwald A, Chhanabhai M, Gaulard P, Klapper W, Calaminici M, Sander B, Thorns C, Campo E, Molina T, Lee A, Pfreundschuh M, Horning S, Lister A, Sehn LH, Raemaekers J, Hagenbeek A, Gascoyne RD, Weller E (2011) Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium. Blood 117(26):7070\u20137078. doi: 10.1182\/blood-2011-04-345256","journal-title":"Blood"},{"issue":"10","key":"2031_CR30","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0277-5379(88)90054-5","volume":"24","author":"JF Mackintosh","year":"1988","unstructured":"Mackintosh JF, Cowan RA, Jones M, Harris M, Deakin DP, Crowther D (1988) Prognostic factors in stage I and II high and intermediate grade non-Hodgkin\u2019s lymphoma. Eur J Cancer Clin Oncol 24(10):1617\u20131622","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"9","key":"2031_CR31","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00277-012-1463-9","volume":"91","author":"TL Lin","year":"2012","unstructured":"Lin TL, Kuo MC, Shih LY, Dunn P, Wang PN, Wu JH, Tang TC, Chang H, Hung YS (2012) The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma. Ann Hematol 91(9):1383\u20131391. doi: 10.1007\/s00277-012-1463-9","journal-title":"Ann Hematol"},{"issue":"10","key":"2031_CR32","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00277-012-1491-5","volume":"91","author":"G Prakash","year":"2012","unstructured":"Prakash G, Sharma A, Raina V, Kumar L, Sharma MC, Mohanti BK (2012) B cell non-Hodgkin\u2019s lymphoma: experience from a tertiary care cancer center. Ann Hematol 91(10):1603\u20131611. doi: 10.1007\/s00277-012-1491-5","journal-title":"Ann Hematol"},{"issue":"7","key":"2031_CR33","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0277-5379(84)90159-7","volume":"20","author":"WP Steward","year":"1984","unstructured":"Steward WP, Todd ID, Harris M, Jones JM, Blackledge G, Wagstaff J, Anderson H, Wilkinson PM, Crowther D (1984) A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin\u2019s lymphoma. Eur J Cancer Clin Oncol 20(7):881\u2013889","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"2","key":"2031_CR34","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12032-009-9211-2","volume":"27","author":"R Khera","year":"2010","unstructured":"Khera R, Jain S, Kumar L, Thulkar S, Vijayraghwan M, Dawar R (2010) Diffuse large B-cell lymphoma: experience from a tertiary care center in North India. Med Oncol 27(2):310\u2013318. doi: 10.1007\/s12032-009-9211-2","journal-title":"Med Oncol"},{"issue":"12","key":"2031_CR35","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/jn\/118.12.1586","volume":"118","author":"B Hennig","year":"1988","unstructured":"Hennig B, Honchel R, Goldblum SE, McClain CJ (1988) Tumor necrosis factor-mediated hypoalbuminemia in rabbits. J Nutr 118(12):1586\u20131590","journal-title":"J Nutr"},{"issue":"1","key":"2031_CR36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1172\/JCI114419","volume":"85","author":"DA Brenner","year":"1990","unstructured":"Brenner DA, Buck M, Feitelberg SP, Chojkier M (1990) Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia. J Clin Invest 85(1):248\u2013255. doi: 10.1172\/jci114419","journal-title":"J Clin Invest"},{"issue":"2","key":"2031_CR37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1207\/S15327914nc392_8","volume":"39","author":"DC McMillan","year":"2001","unstructured":"McMillan DC, Watson WS, O\u2019Gorman P, Preston T, Scott HR, McArdle CS (2001) Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39(2):210\u2013213. doi: 10.1207\/S15327914nc392_8","journal-title":"Nutr Cancer"},{"issue":"6","key":"2031_CR38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0026-0495(94)90117-1","volume":"43","author":"PE Ballmer","year":"1994","unstructured":"Ballmer PE, Ochsenbein AF, Schutz-Hofmann S (1994) Transcapillary escape rate of albumin positively correlates with plasma albumin concentration in acute but not in chronic inflammatory disease. Metabolism 43(6):697\u2013705","journal-title":"Metabolism"},{"issue":"1","key":"2031_CR39","first-page":"31","volume":"26","author":"A Aviles","year":"1995","unstructured":"Aviles A, Yanez J, Lopez T, Garcia EL, Guzman R, Diaz-Maqueo JC (1995) Malnutrition as an adverse prognostic factor in patients with diffuse large cell lymphoma. Arch Med Res 26(1):31\u201334","journal-title":"Arch Med Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2031-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-014-2031-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2031-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T19:38:07Z","timestamp":1597520287000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-014-2031-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,4]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2031"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2031-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,4]]}}}